Open AccessFeasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study
Author(s) -
Serdar Kabataş,
Erdinç Çivelek,
Eyüp Can Savrunlu,
Necati Kaplan,
Osman Boyalı,
Furkan Diren,
Halil Can,
Ali Genç,
Tunç Akkoç,
Erdal Karaöz
Publication year - 2021
Publication title -
world journal of stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.907
H-Index - 18
ISSN - 1948-0210
DOI - 10.4252/wjsc.v13.i5.470
Subject(s) - mesenchymal stem cell , medicine , hypoxic ischemic encephalopathy , encephalopathy , stem cell , hypoxia (environmental) , bioinformatics , pathology , biology , microbiology and biotechnology , chemistry , organic chemistry , oxygen
Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of death and long-term neurological impairment in the pediatric population. Despite a limited number of treatments to cure HIE, stem cell therapies appear to be a potential treatment option for brain injury resulting from HIE.